[Pharmacodynamic optimization of ceftazidime against Pseudomonas aeruginosa: continuous infusion or intermittent administration?]

Rev Esp Quimioter. 2005 Mar;18(1):21-5.
[Article in Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacokinetics*
  • Ceftazidime / administration & dosage*
  • Ceftazidime / pharmacokinetics*
  • Humans
  • Infusions, Intravenous
  • Pseudomonas Infections / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Ceftazidime